Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...
Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...
Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.
The research team of Professor Sin Gon Kim and Professor Nam Hoon Kim of department of internal medicine (Endocrinology and Metabolism) of Korea ...
Among older adults and adults with low atherosclerotic cardiovascular disease risk, use of aspirin decreased after 2019.
About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage company developing a new class of genetic medicines for cardiovascular disease with the potential to transform ...
Now, picture it knowing that in 2022 alone, the CDC said one in every 3 female deaths was due to heart disease. That’s a ...
Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...
My cholesterol has been on the rise for the past few years – and not just a slow creep. For most of my life, my LDL (often referred to as ...
A team of US researchers has found that for people with HIV, current risk models underestimated cardiovascular events in both ...
Background Primary prevention strategies for cardiovascular disease (CVD) conventionally rely on 10-year risk estimates of ...
Cardiologists reveal the unexpected symptoms of clogged arteries and underlying heart disease that you should know about.